About
Dr. Jon Oatley conceptualized NexGen Sire technology and directed modification of traits in agriculturally relevant animals over a decade ago. Rising to become one of the most awarded and referenced scientists in the space, Dr. Oatley refined the technology to the commercial-ready product it is today. Breeders around the globe in species across the agricultural spectrum seek out our NexGen Sire technology to massively improve their herds.
The technology patent was secured by the Tier One research university and leading veterinary medicine organization where Dr. Oatley is a prominent researcher. One of the top in the world, the university exclusively licensed the technology to APYS Biotechnology where production of NexGen Sire animals for breeder clients has taken flight. No other company in the world is able to deliver this technology and these kinds of outsized production gains to large-scale livestock breeders.
The final piece of the puzzle is APYS Biotechnology’s leadership and cutting edge R&D organization. Having spent over a decade in the animal health industry, this team represents one of the most influential and highly connected groups from animal pharmaceuticals and biotechs, breeding technology companies, herd operations, food production, and other industries.
All told, APYS Biotechnology is not only changing the face of livestock breeding potential but brings together the minds that currently are shaping agriculture and food production globally.